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Abstract 
Background: Toxoplasmosis is a zoonotic disease with widespread distribution throughout the world. It is caused by the 
protozoan parasite Toxoplasma gondii. As laboratory diagnosis of toxoplasmosis is not straightforward, this study was 
aimed to compare the sensitivity and specificity of conventional and unconventional methods of diagnosis based on the 
measurement of IgM and IgG for determination of the best method. 
Methods: One hundred suspected cases of toxoplasmosis referred to two laboratories in Tehran and Karaj were entered into 
this comparative analytical study. The serum specimens of these cases were tested with ELISA, IFA, chemiluminescence 
(CLIA) and ELFA for presence of IgG and IgM.  
Results: When compared with the ELFA IgG method, the CLIA IgG had the highest sensitivity, specificity, and positive 
and negative predictive values (100%). In comparison with ELFA IgM method, CLIA IgM and ELISA IgM had the same 
sensitivity (92%), but the sensitivity of ELISA IgM (100%) was higher than CLIA IgM (97.3%). The positive and negative 
predictive values of ELISA IgM were 100% and 97.4%, respectively and those of CLIA IgM were 96% and 98%, in that order. 
Conclusion: Although, the reliability of the compared methods are close to each other, the automatic methods (CLIA, 
ELFA) are preferred because of high reproducibility, less personnel costs, shorter test time and etc. Therefore, we recom-
mend application of these methods for diagnosing of toxoplasmosis and re-emphasize that these are the most suitable tests 
for measurement of toxoplasma IgM levels.  
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Introduction 
Toxoplasmosis is a zoonotic disease (1, 2). Se-
rological studies have shown than this parasite 
infects humans and other endothermic verte-
brates. It is estimated that about one third of the 
world population are infected with toxoplasmo-
sis (2). Two forms of congenital and acquired in-
fections have been described in humans of which, 
the impact of congenital toxoplasmosis on pa-
tient’s health is higher. Toxoplasmosis has a va-
riety of clinical manifestations and can be mis-
taken with other diseases. Therefore, confirmation 
of diagnosis of this parasitic infection is neces-
sary by laboratory tests (2) including parasitical 
and serological methods. Although, the number 
of cases with toxoplasmosis is high, a sensitive 
and suitable method is not applied for detection 
of this infection in most diagnostic laboratories, 
which will lead to mismanagement of the involved 
cases.  
Automated technique including CLIA (Chemilu-
minescence Immuno Assay) and ELFA (Enzyme 
Linked Fluorescent Assay) are partially new 
method for diagnosis of toxoplasmosis that have 
several advantages including reproducibility, cost 
effectiveness etc (3). 
This study was aimed to compare the validity in-
dex of conventional and new methods of di-
agnosis based on the measurement of IgM and 
IgG for determination of the best method. 
 
Materials and Methods 
One hundred suspected cases of toxoplasmosis 
referred by clinicians to two laboratories in Tehran 
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(Masoud laboratory) and Karaj (central labora-
tory of Fardis in west of Tehran Province) were 
entered into this comparative analytical study by 
convenience sampling. The cases were selected 
from a wide age range and nearly equal num-
bers of both genders. After preparation of serum 
samples, their IgG and IgM levels were meas-
ured by ELISA, CLIA (Chemiluminescence Im-
muno Assay), IFA (Indirect Immuno Fluorescent) 
and ELFA (Enzyme Linked Fluorescent Assay). 
ELISA method 
Purified antigens from the cell membrane of 
Toxoplasma gondii were used for coating of the 
solid phase (microplates) (Toxoplasma IgG and 
IgM kits, Genesis Diagnostics, UK). Diluted se-
rum specimens (1:100) were added to the solid 
phase and incubated for 20 min. After washing, 
the plates were incubated for 20 min with rabbit 
anti-human antibody conjugated to horse radish 
peroxidase and washed. Then, the samples were 
developed by TMB enzyme substrate for 10 min. 
The absorbance (OD) was measured at 450 nm.  
IFA method 
This test was performed using Toxoplasma whole 
body antigen (Pasture Institute, Iran) for coating the 
solid phase and IgG-IFA and IgM-IFA kits (Ba-
harafshan, Iran). Different diluted serum samples 
(1:20, 1:100, and 1:200) were added to the solid 
phase and the bound antibodies were detected 
with fluorescein-labeled anti-human antibody. Posi-
tive samples showed a green fluorescent color. 
Chemiluminescence method 
This method was performed using IgG and IgM 
CLIA kits (Diasorin, USA) and fully automated 
LIAISON system. For CLIA IgG, paramagnetic 
particles (solid phase) were coated with Toxoplasma 
antigen from a whole-cell lysate. For CLIA IgM, 
the magnetic particles were coated with a mono-
clonal IgG antibody to human IgM. Magnetic 
particles were incubated in serum for 10 min 
and washed three times. The samples were then 
incubated with a monoclonal anti-human antibody 
coupled with an isoluminol derivative for a fur-
ther 10 min. After a final wash, the chemilumi-
nescence signal was generated and measured by 
a photomultiplier. 
ELFA method 
This method was performed using IgG and IgM 
ELFA kits (bioMérieux, France) and VIDAS 
system. The assay principle combines an enzyme 
immunoassay method with a final fluorescent de-
tection. In ELFA IgG, antibody was detected by 
membrane and cytoplasmic Toxoplasma antigens 
coated on the solid phase receptacle (SPR). In 
ELFA IgM method, the SPR was coated by 
anti-human M chain antibodies. The bound an-
tibody was then incubated with alkaline phos-
phatase-conjugated monoclonal anti-human an-
tibody and the fluorescent substrate 4-methyl um-
belliferyl phosphate. The conjugated enzyme cata-
lyzed this substrate into a fluorescent product 
(4-methyl umbelliferone), and the absorbance was 
measured at 450 nm.  
Statistical methods 
Data were analyzed using kappa test and Chi-
square. ELFA test chooses as gold standard. 
 
Results 
Validity index (sensitivity, specificity, positive pre-
dictive value and negative predictive value) of 
mention diagnostic tests compared with statisti-
cal methods. Highest sensitivity and specificity 
between these tests belong to ELFA IgG test 
and CLIA IgG test and ELFA IgM with 100% 
(Table 1). 
In ELISA IgG method that routinely used in 
laboratories, 73 specimens were positive, 23 were 
negative, and 2 positive and 2 negative specimens 
were not confirmed by this test. Sensitivity and 
specificity were 97.3%, and 92%, respectively. 
Agreement between this method and ELFA IgG 
was 96% (Table 1 and 2). 
IFA method 
In this method, 73 specimens were positive, 24 
specimens were negative, and 2 positive and 1 
negative specimens were not confirmed by ELFA 
IgG method. Sensitivity and specificity were 97.3%, 
and 96%, respectively, and positive and negative 
predictive values were 98.6% and 92%. Agree-
ment between this method and ELFA IgG was 
97% (Table 1 and 2). 
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Positive predictive value 
(%) 
Negative predictive value 
(%) 
CLIA IgG 100 100 100 100 
ELISA IgG 97.3 92 97.3 92 
IFA 97.3 96 98.6 92 
CLIA IgM 92 97.3 92 97.3 
ELISA IgM 92 100 100 97.4 
 
Table 2: Agreement of comparative methods 
 
 CLIA IgG ELISA IgG IFA CLIA IgM ELISA IgM 
Agreement of methods in comparison with 
ELFA IgG (%) 
100 96 97 96 98 
 
Discussion 
According to table 1 and 2 and in comparison 
with ELFA IgG method, CLIA IgG method was 
the most sensitive and specific method with high-
est positive and negative predictive values (100%). 
It was in complete agreement with ELFA IgG 
method. The results of IFA and ELISA IgG 
methods were close to each other. The results of 
CLIA and ELISA IgM were also close to each other. 
In a study performed in USA, four methods in-
cluding ELFA-VIDAS system, OPUS-fluores-
cence system, ELISA-Abbot IMx system, and 
ELISA-Platelia system were compared with each 
other. All the systems were fully automated. The 
results showed that the most specific assay for 
IgM antibody detection was ELFA IgM method. 
This method also had the highest positive pre-
dictive value (80.8%). For IgG antibody, all com-
parative methods had similar sensitivities, speci-
ficities, and positive and negative predictive val-
ues (3). In another study, the ELFA method was 
used for equivocal specimens. The patients were 
evaluated between the first and the third month 
after symptom onset that ELFA IgG had %100 
and ELFA IgM had 81.8% sensitivity respectively 
(4).  
In current study, as the methods under investi-
gation showed fairly similar reliabilities, other 
aspects of these assays were considered. In IFA 
and ELISA methods, the different stages of the 
tests are performed manually. As the result, the 
reproducibility of the tests were less, the personnel 
were exposed to more chemical hazards, and the 
probability of the effect of the environmental fac-
tors on the results was more when compared 
with automated methods. In addition, reduplica-
tion of the assays with a few specimens was very 
expensive and storage of specimens for next as-
say caused more intensive labor. But, in ELFA 
and CLIA methods, the stages for performing the 
test were automatic, therefore the time needed 
for performing the assays was shorter (5, 6), 
and operator and technical mistakes were omitted. 
In two latter methods, the reproducibility of tests 
was high and personnel costs were low. The 
stability of calibration (for 2 weeks) led not 
only to the faster performance of the tests with 
higher precisions, but also omission of the cost 
for multiple calibrations (6). Also, the higher limit 
of measurement enabled application of undiluted 
serum. In addition, the VIDAS system could 
electronically transfer the analysis results to the 
laboratory information system minimizing the 
operator’s data entry errors. The ELFA method 
had the advantage of elimination of carryover 
due to application of specific SPR for each strip. 
Its other advantage is simple mechanical con-
struction of VIDAS system, which keeps the 
maintenance costs of this system lower than other 
systems, and makes its operation easy with a 
very little training. ELFA method had the shortest 
incubation stage and overall run-time (7). Among 
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four techniques, ELFA method could be run 
straightforward at any time with no need to a 
preparatory stage (6). The availability of avidity 
kits for ELFA and CLIA assays makes precise 
determination of the time of infection possible (8). 
This can be important in the diagnosis of infection 
in pregnant women. Also, it can prevent unnec-
essary treatments that will lead to economical 
and psychological damages (5, 9). 
It can be concluded that for Toxo IgG test, a 
diagnostic laboratory should choose an assay 
that suits its own circumstance in terms of costs, 
time, speed etc. But, considering the vital impor-
tance of Toxo IgM assay, it is recommended 
that this test is preferably performed by ELFA 
method, and when it is not available, by CLIA 
as an alternative. 
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